hrp0095fc2.6 | Bone, Growth Plate and Mineral Metabolism | ESPE2022
Ertl Diana-Alexandra
, Mantovani Giovanna
, Perez de Nanclares Guiomar
, Gleiss Andreas
, Hanna Patrick
, Marta Elli Francesca
, Pereda Arrate
, Rothenbuhler Anya
, Audrain Christelle
, Berkenou Jugurtha
, Linglart Agnes
Background: Pseudohypoparathyroidism 1A, newly classified as inactivating PTH/PTHrP signaling disorder type 2 (iPPSD2), is defined by resistance to parathyroid hormone, short stature and early-onset obesity. Short stature is caused by skeletal dysplasia and additionally, in some cases, also by the coexistence of growth hormone deficiency, as other hormonal resistances might be present (e.g. thyroid-stimulating hormone, growth hormone releasing hormone (GHRH), ...